Cardiovascular Diabetology

official impact factor 2.72

Open Access Highly Access

The need for a large-scale trial of fibrate therapy in diabetes: the rationale and design of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. [ISRCTN64783481]

The FIELD Study Investigators

Cardiovascular Diabetology 2004, 3:9 doi:10.1186/1475-2840-3-9

Accesses  

  • Last 30 days: 73 accesses
  • Last 365 days: 765 accesses
  • All time: 11882 accesses

Cited by

BioMed Central: 3 citations